Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Litigation Details for LLC v. RPost Communications Limited (D. Ariz. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard LLC v. RPost Communications Limited (D. Ariz. 2014)

Docket   Start Trial Date Filed 2014-01-22
Court District Court, D. Arizona Date Terminated
Cause 35:271 Patent Infringement Assigned To James A. Teilborg
Jury Demand Both Referred To
Patents 5,008,294
Attorneys Brian William LaCorte; John L Cuddihy; Jonathon Andrew Talcott; Karen J Sepura Fouts; Kenneth Michael Motolenich-Salas; Kimberly Anne Warshawsky; Lewis Emery Hudnell , III; Michael Benjamin Dvoren
Firms Ballard Spahr LLP Phoenix, AZ; Ballard Spahr LLP Washington, DC; Hudnell Law Group PC; Weiss & Moy PC - E Grand Rapids, MI
Link to Docket External link to docket
Small Molecule Drugs cited in LLC v. RPost Communications Limited
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for LLC v. RPost Communications Limited (D. Ariz. 2014)

Date Filed Document No. Description Snippet Link To Document
2016-06-07 344 913 23 Patent, col. 1 ll. 33–37; (Docs. 258 at 5–8; 294 at 26).13 In fact, the ‘913 Patent’s 24 …not” that a patent 13 is un-patentable. 35 U.S.C. § 324(a). A CBM patent excludes patents for “technological…foreign and U.S. patents, the Tomkow 14 Patents, RMail Patents, and pending patent applications, … ’219 patent (an RMail 24 Patent), along with one Tomkow Patent and three other patents, was listed…various patents 25 (the “Asserted Patents”)2 after RPost attempted to enforce those patents against External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.